This entry was posted on Tuesday, November 18th, 2008 at 12:38 pm and is filed under Plastic Surgery. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Advances in breast surgery have this year hit an all time high, with the introduction of Macrolane to the UK and with the growing popularity of Transaxillary Incision. Both procedures equal great results without unsightly scars.
SurgiCare, a leading UK cosmetic surgery provider, is always looking for the next advancement in cosmetic procedures in order to offer patients different options to match different required results. Surgicare works with a portfolio of surgeons, such as Egon Eder, who specialise in pioneering new procedures.
The non surgical arena is Surgicare’s fastest growing offering, as well as sustained rapid growth in Breast Augmentations, and it is a natural step to offer Macrolane to its ever evolving portfolio.
Egon Eder explains the benefits: “Macrolane is perfect for women who want to enhance the natural shape of their breasts. Perhaps they have lost volume after child birth or weight loss or they want to correct uneven breast size. Macrolane involves an injectable treatment, similar to a dermal filler and is carried out under a local anaesthetic. One of the main advantages of using Macrolane for breast enhancement is seeing the results instantly as well as the treatment leaving no scarring. Obviously each patient is different and the average result will last between 12-18 months. I would advise that patients have a yearly top-up to maintain optimum results.
Egon Eder is also a specialist in Transaxillary Incision (transax or armpit incision). This type of incision is used in the placement of implants for breast augmentations. To avoid scarring, an incision is made in the natural folds of the armpit tissue then a channel is created up to the breast. The implant is then inserted and moved through the channel and positioned and centered behind the nipple. Egon Eder said: “The biggest advantage with the Transaxillary Incision is that the scar is not on the breast.”
Mark Bury, chief executive of Surgicare says: “We are constantly looking to evolve our surgical and non-surgical offering and this year seems to be the year breast surgery has taken yet another step. With the help of our surgeons like Egon Eder, we will be able to offer new techniques across our entire cosmetic portfolio.”
For more information or to arrange a consultation with SurgiCare call 0800 62 22 22 or visit http://www.surgicare.co.uk